Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Pelican Bay Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
"The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-quality compounders AECOM, FactSet, and Zoetis at attractive valuations."
Pelican Bay Capital Management's Concentrated Value strategy performed strongly in Q4 2025, gaining 8.5% net of fees and generating 4.7% of alpha over the Russell 1000 Value Index. Performance was led by Micron and Barrick Gold. During the quarter, the manager executed key portfolio rotations: exiting positions in Alphabet (GOOG), CME Group (CME), and ON Semiconductor (ON) due to valuation and structural hurdles. These funds were redeployed into three new compounders: AECOM (ACM), FactSet Research Systems (FDS), and Zoetis (ZTS). Positions in homebuilders Builders FirstSource and Toll Brothers were also increased during a rate-driven temporary sell-off.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Growth Outlook
Market outlook remains above average conviction: The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Risk Appetite
Risk appetite posture is above average conviction: The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Forward Guidance
Forward guidance signal: The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Language Signal
Tone analysis indicates above average conviction language: The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
Time Horizon
Investment time horizon reflects a high conviction orientation. The PBCM Concentrated Value portfolio delivered 8.5% in Q4 2025, generating significant alpha through tactical rotation—exiting fully-valued Alphabet and ON Semi to buy high-qualit...
